The Medicines Patent Pool (MPP) has signed a voluntary licence agreement with Japanese pharmaceutical company, Shionogi, to enable generic companies to produce its COVID-19 antiviral treatment pill candidate, provided it gets regulatory approval. The pill, ensitrelvir fumaric acid, has already shown efficacy in a phase 2/ 3 trial involving 1,821 COVID-19 patients from Japan, South […] Continue reading ->
Leaders of a coalition of former Tuareg and Arab rebels in Mali signed a written pledge on civilian protections for health and medical facilities during armed conflict, reflecting global efforts to stem attacks on health facilities, transport, and patients that have became more frequent since the onset of the COVID-19 crisis. The two leaders with […] Continue reading ->
Routine childhood immunisation across 57 low income countries declined slightly for the second consecutive year in 2021, following massive pandemic-related interruptions in vaccine coverage in 2020, according to Gavi, the Vaccine Alliance. Vaccine coverage stood at 77%, one percent less than in 2020.  Preliminary data between January and May 2022, however, shows signs of improvement […] Continue reading ->
At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading ->